Home Medicine The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
Article
Licensed
Unlicensed Requires Authentication

The Index of Individuality Is Often a Misinterpreted Quantity Characteristic

  • Per Hyltoft Petersen , Callum G. Fraser , Sverre Sandberg and Henk Goldschmidt
Published/Copyright: June 1, 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 37 Issue 6

Abstract

The concept of the “index of individuality” was introduced by Eugene Harris in 1974. The index of individuality, calculated as (CVA2 + CVI2)1/2/CVG, where CvA, CvI, and CvG are analytical, within-subject, and between-subject coefficients of variation respectively, has been used by many to investigate the utility of conventional population-based reference values. For a high index of individuality, >1.4, it has been said that reference intervals will be more useful than for a low index, < 0.6. The validity of these concepts is investigated here and a number of our findings are at odds with the generally held opinion. The index of individuality has no impact on the fraction of individuals classified using population-based reference values, as long as the change in concentration from the usual state is of the same absolute magnitude and one sample is assayed to detect disease. However, when a measurement falling outside a reference limit is repeated in order to verify the finding, the index of individuality has considerable influence. For quantities with very low indices, the repeat test result, will be close to the first and give no new information, whereas for quantities with high indices, a repeat test will decrease the number of true positives and false positives.

:
Published Online: 2005-06-01
Published in Print: 1999-06-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Meetings and Awards
  2. Are Cardiac Troponins the Myocardial Markers for the New Millenium?
  3. Leukocyte Activation Markers in Clinical Practice
  4. Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
  5. Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
  6. Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
  7. Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
  8. The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
  9. The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
  10. Assessment of Package Inserts for Diagnostic Kits
  11. External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
  12. Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
  13. Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
  14. Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
  15. Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
  16. Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
  17. Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Downloaded on 25.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.102/html
Scroll to top button